FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lilly
The modest benefits of the treatment, donanemab, made by Eli [...]
F.D.A. Delays Action on Closely Watched Alzheimer’s Drug
Eli Lilly’s donanemab was expected to be approved this month, [...]
New Study Finds Alzheimer’s Drug Donanemab Can Modestly Slow Memory Decline
A trial of donanemab, an experimental drug, found it modestly [...]